277 related articles for article (PubMed ID: 1569386)
21. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
Breyer ED; Le NA; Li X; Martinson D; Brown WV
J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
[TBL] [Abstract][Full Text] [Related]
22. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM
J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
[TBL] [Abstract][Full Text] [Related]
23. Human triglyceride-rich lipoprotein apo E kinetics and its relationship to LDL apo B-100 metabolism.
Millar JS; Lichtenstein AH; Ordovas JM; Dolnikowski GG; Schaefer EJ
Atherosclerosis; 2001 Apr; 155(2):477-85. PubMed ID: 11254920
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
25. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma.
Campos E; Kotite L; Blanche P; Mitsugi Y; Frost PH; Masharani U; Krauss RM; Havel RJ
J Lipid Res; 2002 Mar; 43(3):365-74. PubMed ID: 11893772
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
27. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
Sehayek E; Eisenberg S
J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Bjorkegren J; Packard CJ; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
J Lipid Res; 1996 Jan; 37(1):76-86. PubMed ID: 8820104
[TBL] [Abstract][Full Text] [Related]
31. Characterization of apolipoprotein B-containing lipoproteins separated by preparative free flow isotachophoresis.
Nowicka G; Brüning T; Grothaus B; Kahl G; Schmitz G
J Lipid Res; 1990 Jul; 31(7):1173-86. PubMed ID: 2401852
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
Desai NK; Ooi EM; Mitchell PD; Furtado J; Sacks FM
Atherosclerosis; 2015 Aug; 241(2):326-33. PubMed ID: 26071654
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
Dergunov AD
Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
[TBL] [Abstract][Full Text] [Related]
37. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles.
Goulinet S; Chapman MJ
J Lipid Res; 1993 Jun; 34(6):943-59. PubMed ID: 8354960
[TBL] [Abstract][Full Text] [Related]
38. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
39. ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.
Hinsdale ME; Sullivan PM; Mezdour H; Maeda N
J Lipid Res; 2002 Sep; 43(9):1520-8. PubMed ID: 12235184
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
Evans AJ; Huff MW; Wolfe BM
J Lipid Res; 1989 Nov; 30(11):1691-701. PubMed ID: 2614271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
